Janvier Labs SAS - Company Review
Janvier Labs SAS - Company ReviewSummary
Janvier Labs SAS (Janvier) is a provider of rodent research models and associated services. The company provides laboratory services including catheterization, excision and ligation surgery; and transgenic services such as rederivation and cryopreservation; customized breeding in isolators. Its pathological models recreate hypothetical and described mechanisms in human and animal disease and used for regular monitoring. Janvier provides its services for biomedical research with the experimental materials. The company offers different species of rodent including inbred rats, outbred rats, mutant mice, hybrid mice, and gold hamsters, among others. Janvier is headquartered in Laval, France.
This comprehensive company report of Janvier Labs SAS provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.